Translating Pharmacometrics to a Pharmacoeconomic Model of COPD

Value in Health ◽

10.1016/j.jval.2016.07.006 ◽

2016 ◽

Vol 19 (8) ◽

pp. 1026-1032 ◽

Author(s):

Julia F. Slejko ◽

Richard J. Willke ◽

Jakob Ribbing ◽

Peter Milligan

Keyword(s):

Pharmacoeconomic Model

Download Full-text

PCV27: A PHARMACOECONOMIC MODEL TO EVALUATE TREATMENT OPTIONS FOR DVT PHARMACOPROPHYLAXIS

Value in Health ◽

10.1046/j.1524-4733.2001.40202-101.x ◽

2001 ◽

Vol 4 (2) ◽

pp. 105

Author(s):

WJ Spruill ◽

WE Wade ◽

RB Leslie

Keyword(s):

Treatment Options ◽

Pharmacoeconomic Model

Download Full-text

Validation of predictive pharmacoeconomic model of introduction of medicinal product ibrutinib into chronic lymphatic leukemia therapy practice in the territory of the Russian Federation

Pharmacoeconomics theory and practice ◽

10.30809/phe.3.2015.7 ◽

2015 ◽

Vol 3 (3) ◽

pp. 42-45 ◽

Author(s):

R.I. Yagudina ◽

D.G. Tishchenko

Keyword(s):

Medicinal Product ◽

Russian Federation ◽

Chronic Lymphatic Leukemia ◽

Lymphatic Leukemia ◽

Pharmacoeconomic Model ◽

The Russian Federation

Download Full-text

An Ideal Pharmacoeconomic Model for Indian Scenario

Journal of Pharmaceutical Research ◽

10.18579/jpcrkc/2015/0/0/79194 ◽

2015 ◽

Vol 0 (0) ◽

pp. 41

Author(s):

Venkatraghavan Sundaram

Keyword(s):

Pharmacoeconomic Model ◽

Indian Scenario

Download Full-text

PAR26 COST-UTILITY OUTCOMES SIMULATION MODEL FOR OSTEOARTHRITIS (OA) AND RHEUMATOID ARTHRITIS (RA) PATIENTS (COSMO): DEVELOPMENT AND VALIDATION OF A PHARMACOECONOMIC MODEL

Value in Health ◽

10.1016/s1098-3015(10)65733-6 ◽

2004 ◽

Vol 7 (6) ◽

pp. 668-669 ◽

Author(s):

L Niculescu ◽

AW Using ◽

PJ Neumann

Keyword(s):

Rheumatoid Arthritis ◽

Simulation Model ◽

Cost Utility ◽

Pharmacoeconomic Model ◽

Development And Validation

Download Full-text

PCASE7 INCLUDING A PHARMACOECONOMIC MODEL IN THE FORMULARY REVIEW PROCESS OF NEW

Value in Health ◽

10.1016/s1098-3015(10)69147-4 ◽

2007 ◽

Vol 10 (3) ◽

pp. A204

Author(s):

J Grossomanides ◽

C Possidente

Keyword(s):

Review Process ◽

Pharmacoeconomic Model

Download Full-text

Misoprostol Vaginal Insert Pharmacoeconomic Model for 5 European Countries

Value in Health ◽

10.1016/j.jval.2014.08.1554 ◽

2014 ◽

Vol 17 (7) ◽

pp. A508

Author(s):

J. Walczak ◽

A. Bierut ◽

J. Dowgiallo ◽

K. Pacocha ◽

I. Pieniazek ◽

...

Keyword(s):

European Countries ◽

Pharmacoeconomic Model

Download Full-text

A Pharmacoeconomic Model Comparing Two Long-Acting Treatments for Overactive Bladder

Journal of Managed Care Pharmacy ◽

10.18553/jmcp.2002.8.5.343 ◽

2002 ◽

Vol 8 (5) ◽

pp. 343-352 ◽

Author(s):

Les Noe ◽

Russell Becker ◽

Todd Williamson ◽

Donny Chen

Keyword(s):

Overactive Bladder ◽

Pharmacoeconomic Model ◽

Download Full-text

Pharmacoeconomic model of enoxaparin versus heparin for prevention of deep vein thrombosis after total hip replacement

American Journal of Health-System Pharmacy ◽

10.1093/ajhp/54.10.1185 ◽

1997 ◽

Vol 54 (10) ◽

pp. 1185-1190 ◽

Author(s):

David W. Hawkins ◽

Paul C. Langley ◽

Kem P. Krueger

Keyword(s):

Deep Vein Thrombosis ◽

Total Hip Replacement ◽

Hip Replacement ◽

Total Hip ◽

Vein Thrombosis ◽

Pharmacoeconomic Model ◽

Download Full-text

Treatment of Major Depressive Disorder in Patients Failing Initial Therapy: An Excel-Based Pharmacoeconomic Model

Journal of Managed Care Pharmacy ◽

10.18553/jmcp.2007.13.s6-a.1 ◽

2007 ◽

Vol 13 (6 Supp A) ◽

pp. 1-18

Author(s):

Daniel C. Malone ◽

John G. Tierney

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Initial Therapy ◽

Major Depressive ◽

Pharmacoeconomic Model

Download Full-text

PCN2I A PHARMACOECONOMIC MODEL OF THE COST-EFFECTIVENESS OF GEFITINIB (“IRESSA”) COMPARED WITH BEST SUPPORTIVE CARE (BSC) IN THIRD-LINE TREATMENT OF PATIENTS WITH REFRACTORY ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) IN THE UK

Value in Health ◽

10.1016/s1098-3015(10)65755-5 ◽

2004 ◽

Vol 7 (6) ◽

pp. 675-676 ◽

Author(s):

AE Ratcliffe ◽

SM Beard ◽

S Wolowacz

Keyword(s):

Lung Cancer ◽

Best Supportive Care ◽

Line Treatment ◽

Small Cell Lung ◽

Pharmacoeconomic Model ◽

The Uk ◽

The Cost ◽

Third Line Treatment

Download Full-text